Landec Announces Special Conference Call Regarding Acquisition of Lifecore Biomedical Scheduled for Today Monday May 3, 2010 at 11 AM Eastern Time
MENLO PARK, Calif., May 03, 2010 (BUSINESS WIRE) --Landec Corporation (Nasdaq:LNDC) has scheduled a Special Conference Call regarding the acquisition of Lifecore Biomedical, Inc. which was announced today in a separate press release. The Special Conference Call will be held today Monday May 3, 2010 at 11 AM Eastern Time.
The teleconference and webcast are open to all interested parties at 11:00 AM Eastern Time (8:00 AM Pacific Time). The teleconference can be accessed by calling 866-244-4629 or 703-639-1176. Please log in 5 - 10 minutes prior to the beginning of the call.
This call is also being webcast by Thomson/CCBN and can be accessed at Landec's web site at www.Landec.com on the Investor Relations page. The webcast will be available for 30 days through June 2, 2010. A replay of the teleconference will be available for one week until midnight Eastern Time May 10, 2010, by calling 888-266-2081 or 703-925-2533. The access code for the replay is 1454153.
For further information, please call Greg Skinner at 650-261-3677.
The webcast is also being distributed over Thomson/CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through Thomson's individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in Thomson's Individual Investor Network such as America Online's Personal Finance Channel, Fidelity Investments® (Fidelity.com) and others. Institutional investors can access the call via Thomson's password protected event management site, StreetEvents (www.streetevents.com). StreetEvents allows institutional investors to identify, organize, and track the hundreds of conference calls that occur each day during earnings season, to download events of interest to their Outlook calendar, and to RSVP to events online.
Landec is a materials science company, leveraging its capability in polymer science and bio-application development to commercialize new products within a variety of life science fields, including food, agricultural, personal care and drug delivery applications. With its Intelimer® polymers, Landec is able to customize its proprietary polymer materials for each application through the manipulation of their unique controlled release, temperature activation and/or biocompatibility properties. Landec's subsidiary, Apio Inc., has leveraged Landec's BreatheWay® membrane to become the leader in US fresh-cut specialty vegetables. Landec Ag offers a full solution of seed coatings and enhancements that work with the latest genetic technologies to drive continuous improvements in crop yield. Through long-standing partnerships, Landec has commercialized dozens of personal care and adhesive products. For more information about the Company visit Landec's website at www.landec.com.
SOURCE: Landec Corporation
Gregory S. Skinner, 650-261-3677
Vice President Finance and CFO